Ga naar de inhoud Skip to sidebar Ga naar de footer

Oxurion

Voorkennis

Press releases classified as inside information under MAR (Market Abuse Regulation)

HomeAlle berichten

Voorkennis Nieuws Regulated

Oxurion signs a letter of intent for the acquisition of an international CRO

Voorkennis Nieuws Regulated

Oxurion Extends Its Financing Program

Voorkennis Nieuws Regulated

Oxurion confirms continuation of discussions regarding its proposed acquisition of a French CRO

februari 27, 2026

General Voorkennis Nieuws Regulated

Axiodis CRO accelerates its sales and marketing strategy to support ambitious growth driven by Oxurion

februari 16, 2026

General Voorkennis Nieuws Regulated

Oxurion announces the temporary suspension of the financing programme dedicated to investments in digital assets and crypto-assets

EN NL FR

januari 19, 2026

Voorkennis Nieuws Regulated

Oxurion secures a binding €30 million financing facility dedicated to investments in digital and crypto-assets

december 1, 2025

Voorkennis Nieuws Regulated

Oxurion ends discussions regarding previously announced preclinical transaction and continues integration of a strategic clinical partner

november 3, 2025

Voorkennis Nieuws Regulated

Oxurion signs letter of intent for the contemplated acquisition of a CRO with strong complementarity to Axiodis

oktober 13, 2025

Voorkennis Nieuws Regulated

Oxurion provides an update related to its investment strategy in digital assets

oktober 9, 2025

General Voorkennis Nieuws Regulated

Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials

september 16, 2025

Voorkennis Nieuws Regulated

Oxurion confirms progress in negotiations related to its treasury diversification strategy; closing of the transaction expected before September 25, 2025

september 1, 2025

Voorkennis Nieuws Regulated

Oxurion Ends R&D Program in Geographic Atrophy and Refocuses on New CRO Activities

augustus 7, 2025

Voorkennis Nieuws Regulated

Oxurion announces it obtained an improved indicative €30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets

augustus 4, 2025

General Voorkennis Nieuws Regulated

Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform

augustus 4, 2025

Voorkennis Nieuws Regulated

Oxurion plans to launch a treasury diversification strategy into digital assets under a €10M indicative agreement with its main investor

Voorkennis Nieuws Regulated

Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025

Voorkennis Nieuws Regulated

Oxurion Announces the Fulfilment of the Second Condition Precedent in the Acquisition of Axiodis

Voorkennis Nieuws Regulated

Oxurion moves forward with the planned acquisition of Axiodis

Voorkennis Regulated

Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO

Voorkennis Nieuws Regulated

Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025

Login
Register